# US 2024/0197938 A1 · Antimicrobial compounds based on glucoheptonic acids and their salts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197938 A1
- Document ID: US20240197938A1
- Status: Published application
- Kind: A1
- Application number: 18/270,508
- Filed: 2022-02-03
- Published: 2024-06-20
- Earliest claimed: 2021-01-04
- Assignees: Harcros Chemicals Inc.
- Applicants: Harcros Chemicals, Inc.
- Inventors: PETER RADFORD; DIANA CRAIN; LARRY MORRIS; KEVIN SIKKEMA; AMOL ASHOK WALKE; JOSE C.J.M.D.S. MENEZES; PRASANTA MAYAPUR
- Web page: https://patentgrep.com/patent/US20240197938A1

## CPC

- A61L 2/18: Liquid substances
- C11D 3/48: Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
- A01N 37/36: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N 47/44: Guanidine; Derivatives thereof
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A01P 3/00: Fungicides
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/416: {Quaternary ammonium compounds (A61K8/35 takes precedence)}
- A61K 8/43: Guanidines
- A61Q 17/005: {Antimicrobial preparations}
- C11D 7/265: {Carboxylic acids or salts thereof}
- C11D 7/28: containing halogen
- C11D 7/3209: {Amines or imines with one to four nitrogen atoms; Quaternized amines}
- A61K 2800/524: Preservatives
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to methods for disinfecting or sanitizing. The invention is also directed to methods for the preparation of certain compounds useful as a disinfectant or sanitizer, such as glucoheptonic acid, chlorhexidine diglucoheptonate, benzalkonium glucoheptonate, and combinations thereof. The invention is still further directed to methods for evaluating a compound for performance in microbial disinfecting or sanitizing.

## Claims

### Claim 1

A method of disinfecting or sanitizing, wherein the method comprises:
contacting an aqueous composition comprising a component selected from the group consisting of glucoheptonic acid, chlorhexidine diglucoheptonate, benzalkonium glucoheptonate, and combinations thereof with a microbial population.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Log Reduction is about 3 or greater, 30 seconds after application.

### Claim 3 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising glucoheptonic acid.

### Claim 4 (depends on 3)

The method of claim 3, wherein the microbial population is contacted with an aqueous composition comprising α-glucoheptonic acid and β-glucoheptonic acid and the composition comprises an α-glucoheptonic acid concentration, based on total isomers of glucoheptonic acid, of about 90% or greater.

### Claim 5 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising chlorhexidine di-α-glucoheptonate.

### Claim 6 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising chlorhexidine di-β73-glucoheptonate.

### Claim 7 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising chlorhexidine di-β81-glucoheptonate.

### Claim 8 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising chlorhexidine di-α-glucoheptonate and chlorhexidine di-β-glucoheptonate and the composition comprises a chlorhexidine di-α-glucoheptonate concentration, based on total isomers of chlorhexidine diglucoheptonate, of about 90% or greater.

### Claim 9 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising chlorhexidine di-α-glucoheptonate and chlorhexidine di-β-glucoheptonate and the composition comprises a chlorhexidine di-β-glucoheptonate concentration, based on total isomers of chlorhexidine diglucoheptonate, of about 25% or greater.

### Claim 10 (depends on 1)

The method of claim 1, wherein the microbial population is contacted with an aqueous composition comprising benzalkonium glucoheptonate.

### Claim 11 (depends on 1)

The method of claim 1, wherein the microbial population comprises C. albicans; S. aureus, S. epidermidis, E. coli, S. abony, L. monocytogenes, or combinations thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein the microbial population comprises SARS-COV-2.

### Claim 13

A method of preparing glucoheptonic acid, the method comprising:
dissolving a glucoheptonate salt in water to form a solution;
combining the solution with an acidic ion exchange resin to form a slurry;
filtering the slurry to remove the ion exchange resin to form glucoheptonic acid;
wherein the conversion of the glucoheptonate salt to glucoheptonic acid is about 99% or greater, about 99.1% or greater, about 99.2% or greater, about 99.3% or greater, about 99.4% or greater, or about 99.5% or greater.

### Claim 14 (depends on 13)

The method of claim 13, wherein the slurry is dried to form the glucoheptonic acid.

### Claim 15 (depends on 13)

The method of claim 13, wherein the acidic ion exchange resin comprises a DOWEX MARATHON MSC and/or LEWATIT MONOPLUS SP 112 H ion exchange resin.

### Claim 16 (depends on 13)

A method of preparing chlorhexidine diglucoheptonate, the method comprising:
combining chlorhexidine and water to form a slurry; and
adding the glucoheptonic acid of claim 13 to the slurry and mixing the combination.

### Claim 17 (depends on 16)

The method of claim 16, wherein the chlorhexidine diglucoheptonate comprises a chlorhexidine di-α-glucoheptonate concentration, based on total isomers of chlorhexidine diglucoheptonate, of about 90% or greater.

### Claim 18 (depends on 16)

The method of claim 16, wherein the chlorhexidine diglucoheptonate comprises a chlorhexidine di-β-glucoheptonate concentration, based on total isomers of chlorhexidine diglucoheptonate, of about 25% or greater.

### Claim 19 (depends on 16)

The method of claim 16, wherein the chlorhexidine diglucoheptonate has a molar ratio of glucoheptonic acid to chlorhexidine of from about 1.5:1 to about 3:1, from about 2:1 to about 2.9:1, from about 2:1 to about 2.8:1, from about 2:1 to about 2.7:1, from about 2:1 to about 2.6:1, or from about 2.1:1 to about 2.6:1.

### Claim 20 (depends on 10)

The method of claim 10, wherein the benzalkonium glucoheptonate is prepared by a method comprising:
combining a benzalkonium salt and a glucoheptonate salt in a container and stirring the combination.

### Claim at position 21

21-31. (canceled)
